Shionogi & Co. Ltd. | |
Stock Exchange | Other OTC |
EPS |
$3.79 |
Market Cap |
$18.08 B |
Shares Outstanding |
324.14 M |
Public Float |
- |
Shionogi & Co. Ltd. ADR | |
Stock Exchange | Other OTC |
EPS |
$0.95 |
Market Cap |
$18.26 B |
Shares Outstanding |
1.27 B |
Public Float |
- |
Shionogi & Co. Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
324.14 M |
Public Float |
- |
Shionogi & Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY420.67 |
Market Cap |
JPY1.97 T |
Shares Outstanding |
316.79 M |
Public Float |
252.87 M |
Address |
3-1-8 Dosho-machi Osaka Osaka 541 Japan |
Employees | - |
Website | http://www.shionogi.co.jp |
Updated | 07/08/2019 |
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan. |